Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OVAS

OvaScience (OVAS) Stock Price, News & Analysis

OvaScience logo

About OvaScience Stock (NASDAQ:OVAS)

Advanced Chart

Key Stats

Today's Range
$5.92
$6.08
50-Day Range
$8.56
$17.10
52-Week Range
$0.66
$1.52
Volume
31,195 shs
Average Volume
163,131 shs
Market Capitalization
$213.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI.

Receive OVAS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OvaScience and its competitors with MarketBeat's FREE daily newsletter.

OVAS Stock News Headlines

Do You Believe In President Trump? Answer This 1 Question
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to Trump’s economic plan. But now there’s a way to protect your retirement without backing down. This free 2025 Wealth Protection Guide reveals how you can use a legal IRS loophole—nicknamed “Piggy Bank”—to shield your savings.
General Catalyst Group V LP's Net Worth
TMRW Life Sciences Names Louis Villalba Chief Executive Officer
See More Headlines

OVAS Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that OvaScience investors own include Synergy Pharmaceuticals (SGYP), OPKO Health (OPK), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Melinta Therapeutics (MLNT), TherapeuticsMD (TXMD) and Bed Bath & Beyond (BBBY).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OVAS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.97 million
Net Margins
-10,128.37%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$290,000.00
Price / Cash Flow
N/A
Book Value
$1.80 per share
Price / Book
3.31

Miscellaneous

Free Float
N/A
Market Cap
$213.19 million
Optionable
Not Optionable
Beta
3.11
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:OVAS) was last updated on 5/31/2025 by MarketBeat.com Staff
From Our Partners